CA2646421A1 - Live attenuated salmonella vaccine - Google Patents

Live attenuated salmonella vaccine Download PDF

Info

Publication number
CA2646421A1
CA2646421A1 CA002646421A CA2646421A CA2646421A1 CA 2646421 A1 CA2646421 A1 CA 2646421A1 CA 002646421 A CA002646421 A CA 002646421A CA 2646421 A CA2646421 A CA 2646421A CA 2646421 A1 CA2646421 A1 CA 2646421A1
Authority
CA
Canada
Prior art keywords
strain
mutant strain
mutant
vaccine
attenuated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002646421A
Other languages
English (en)
French (fr)
Inventor
Henri Marcel Jozef De Greve
Connie Theresia Adriaensen
Jean-Pierre Ernest Clement Hernalsteens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vrije Universiteit Brussel VUB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2646421A1 publication Critical patent/CA2646421A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002646421A 2006-03-20 2006-03-20 Live attenuated salmonella vaccine Abandoned CA2646421A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BE2006/000019 WO2007106956A1 (en) 2006-03-20 2006-03-20 Live attenuated salmonella vaccine

Publications (1)

Publication Number Publication Date
CA2646421A1 true CA2646421A1 (en) 2007-10-11

Family

ID=37430822

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002646421A Abandoned CA2646421A1 (en) 2006-03-20 2006-03-20 Live attenuated salmonella vaccine

Country Status (7)

Country Link
EP (1) EP2004802A1 (ja)
JP (1) JP2009529895A (ja)
AU (1) AU2006340699A1 (ja)
BR (1) BRPI0621489A2 (ja)
CA (1) CA2646421A1 (ja)
MX (1) MX2008012056A (ja)
WO (1) WO2007106956A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080260777A1 (en) 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
US7935355B2 (en) 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
WO2010083477A2 (en) * 2009-01-16 2010-07-22 University Of Maryland, Baltimore Broad spectrum vaccine against non-typhoidal salmonella
US9011871B2 (en) 2011-11-07 2015-04-21 University Of Maryland, Baltimore Broad spectrum vaccine against typhoidal and non-typhoidal Salmonella disease
CZ307672B6 (cs) * 2012-05-30 2019-02-13 VÝZKUMNÝ ÚSTAV VETERINÁRNÍHO LÉKAŘSTVÍ, v.v.i. Vakcína pro orální podání hospodářským zvířatům

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190669B1 (en) * 1998-05-13 2001-02-20 University Of Maryland, Baltimore Attenuated mutants of salmonella which constitutively express the Vi antigen

Also Published As

Publication number Publication date
BRPI0621489A2 (pt) 2011-12-13
AU2006340699A1 (en) 2007-09-27
WO2007106956A1 (en) 2007-09-27
JP2009529895A (ja) 2009-08-27
MX2008012056A (es) 2008-12-18
EP2004802A1 (en) 2008-12-24

Similar Documents

Publication Publication Date Title
US20110052635A1 (en) Live attenuated salmonella vaccine
Salehi et al. Assessment of immunity against avian colibacillosis induced by an aroA mutant containing increased serum survival gene in broilers
CA2877817A1 (en) Attenuated streptococcus suis vaccines and methods of making and use thereof
CA2646421A1 (en) Live attenuated salmonella vaccine
Kremer et al. Evaluation of recombinant Salmonella expressing the flagellar protein fliC for persistence and enhanced antibody response in commercial turkeys
US20190322707A1 (en) Mutated Salmonella Enterica
Wang et al. A triple-sugar regulated Salmonella vaccine protects against Clostridium perfringens-induced necrotic enteritis in broiler chickens
ES2764173T3 (es) Bacterias modificadas para vacunas mejoradas contra la brucelosis
Lee Protection against Salmonella typhimurium, Salmonella gallinarum, and Salmonella enteritidis infection in layer chickens conferred by a live attenuated Salmonella typhimurium strain
KR20080110594A (ko) 약독화 살모넬라 생백신
Barrow et al. Vaccination against Salmonella infections in food animals: rationale, theoretical basis and practical application
US20100260794A1 (en) Live attenuated salmonella vaccine
KR20080105099A (ko) 약독화 살모넬라 생백신
CN102676419B (zh) 一种伤寒沙门氏菌基因缺失菌株及由其制备的疫苗和应用
KR102007455B1 (ko) 방사선에 의한 약독화 생균 백신의 제조 방법 및 이로부터 제조된 약독화 생균 백신 조성물
KR101950931B1 (ko) ptsI 및 crr 유전자 결손된 약독화 살모넬라 타이피뮤리움 균주 및 상기 균주를 이용한 생균 백신 조성물
CN113395980B (zh) 利用放射线制备减毒活疫苗的方法及通过其制备的减毒活疫苗组合物
KR101774863B1 (ko) 살모넬라증 치료를 위한 변이 균주 ｈｉｄ２０９２와 ｈｉｄ２１１４ 및 이를 포함하는 살모넬라증 약제학적 조성물
Pumtang-on Investigation of Campylobacter jejuni and Campylobacter coli colonisation of commercial free-range chickens
Van der Merwe Preliminary investigations into ostrich mycoplasmas: identification of vaccine candidate genes and immunity elicited by poultry mycoplasma vaccines
CN116836900A (zh) 肠炎沙门菌ryhB-1和sopE双基因缺失株及其作为减毒疫苗候选株的应用
Linde et al. Prophylaxis of Salmonella (S.) abortus ovis caused abortions of sheep by a S. typhimurium live vaccine
Windhorst Controlling salmonella in poultry flocks by vaccination
CZ24177U1 (cs) Vakcína pro orální podání hospodářským zvířatům

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20130320